PGEN:NASDAQ
Precigen Inc
$6.96
arrow_upward
+1.61%(+0.11) 1D
Sep 15, 1:58:30 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PGEN...
Open
$6.81
High
$7.00
Low
$6.76
Mkt. cap
2.49B
Avg. vol.
5.20M
Volume
1.21M
52-wk high
$7.72
52-wk low
$2.99
EPS
-$1.10
Beta
1.02
Shares outstanding
358.04M
No. of employees
160
Open
$6.81
High
$7.00
Low
$6.76
Mkt. cap
2.49B
Avg. vol.
5.20M
Volume
1.21M
52-wk high
$7.72
52-wk low
$2.99
EPS
-$1.10
Beta
1.02
Shares outstanding
358.04M
No. of employees
160
News stories
From web sources and news partners
Zacks
·
2 hours ago
Immunocore Hits Enrollment Target in Kimmtrak Label Expansion Study
Zacks
·
2 hours ago
GSK Inks $750M Deal to Add Experimental Blood Cancer Therapy
Profile
Precigen, Inc. is an American biotechnology company. Its president and CEO is Helen Sabzevari.
Intrexon was founded in 1998, and is headquartered in Germantown, Maryland. With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells. Wikipedia
About Precigen Inc
CEOHelen Sabzevari
Employees160
FoundedMay 21, 1998
Headquarters-
SectorBiotechnology
Websiteprecigen.com